HomeTreatment Guides

Condition-Specific Treatment Guides

Comprehensive, evidence-based cannabis treatment protocols for the top 6 conditions with clinical research support. Each guide includes peer-reviewed citations, phased dosing protocols, strain recommendations, drug interactions, and safety considerations.

Conditions Covered

30+

Research Citations

Dosing Protocols

Comprehensive

Safety Warnings

Medical Disclaimer: These guides are for educational purposes only and do not constitute medical advice. Always consult a qualified healthcare provider before initiating cannabis therapy.

Strong

Chronic Pain

The most evidence-supported cannabis indication

Comprehensive protocols for neuropathic, inflammatory, and musculoskeletal pain. Includes opioid-sparing strategies, dosing titration, and strain recommendations.

50M+ Americans affected

79+ RCTs reviewed

6,400+ patients studied

Anxiety Disorders

CBD-dominant approach for the most common mental health condition

Evidence-based CBD protocols for GAD, social anxiety, panic disorder, and performance anxiety. Critical guidance on THC dose-dependent anxiety effects.

40M US adults affected

CBD-first approach

Multiple RCT evidence

Insomnia & Sleep

THC, CBD, and CBN protocols for sleep disorders

Targeted protocols for sleep onset, sleep maintenance, and anxiety-driven insomnia. Covers CBN (the sleep cannabinoid), timing strategies, and tolerance management.

30–35% of adults affected

CBN: the sleep cannabinoid

Tolerance management critical

Pain-Related Insomnia

View Full Guide

Moderate

PTSD

Nightmare suppression and hyperarousal management

Trauma-informed protocols addressing nightmares, hypervigilance, and anxiety. Covers the endocannabinoid deficiency theory of PTSD and adjunct therapy integration.

11–20% of veterans affected

Nightmare suppression: strong evidence

Adjunct to trauma therapy

THC (nighttime)CBD (daytime)

Strong (FDA-Approved)

Epilepsy

FDA-approved CBD therapy for seizure disorders

The strongest evidence base in cannabis medicine. Covers Epidiolex protocols, critical drug interactions with AEDs, and evidence from landmark NEJM RCTs.

Epidiolex FDA-approved 2018

NEJM RCT: 38.9% seizure reduction

Treatment-Resistant Epilepsy

View Full Guide

Strong for CINV

Cancer Support

Symptom management during cancer treatment

Evidence-based protocols for chemotherapy nausea, cancer pain, appetite loss, and palliative care. Critical drug interaction guidance for oncology patients.

Dronabinol FDA-approved 1985

Meta-analysis: 30 RCTs

Critical chemo interactions

Evidence-Based

Every recommendation is backed by peer-reviewed research from NEJM, JAMA, The Lancet, and other top journals.

Patient-Centered

Protocols designed for real-world use, with practical dosing guidance, strain recommendations, and safety information.

Safety First

Comprehensive drug interaction tables, contraindications, and clear guidance on when to seek medical care.